share_log

$25M Bet On This Consumer Cyclical Stock? Check Out These 4 Penny Stocks Insiders Are Aggressively Buying

$25M Bet On This Consumer Cyclical Stock? Check Out These 4 Penny Stocks Insiders Are Aggressively Buying

押注这只消费周期股2500万美元?看看内部人士正在积极买入的这4只便士股
Benzinga ·  2023/05/25 07:11

The Dow Jones closed lower by over 250 points on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

道琼斯指数周三收盘下跌超过250点。当内部人士购买或出售股票时,这表明他们对公司前景的信心或担忧。对便士股感兴趣的投资者和交易者可以将其视为其整体投资或交易决策中的一个因素。

Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform.

以下是近期一些值得注意的细价股内幕交易。欲了解更多,请查看 本辛加的内幕交易 平台。

EVgo

evGo

  • The Trade: EVgo, Inc. (NASDAQ:EVGO) Director David Nanus acquired a total 5,882,352 shares an average price of $4.25. To acquire these shares, it cost around $25 million.
  • What's Happening: EVgo announced pricing of an offering of Class A common stock.
  • What EVgo Does: EVgo owns and operates a public direct current fast charging network in the U.S. EVgo's network of charging stations provides electric vehicle charging infrastructure to consumers and businesses.
  • 交易: evGo, Inc. (纳斯达克股票代码:EVGO)董事戴维·纳纳斯 共收购了 5,882,352 股股票 平均价格为4.25美元。收购这些股票的成本约为2500万美元。
  • 发生了什么: EvGo宣布了A类普通股发行的定价。
  • evgo 会做什么: evGo 在美国拥有并运营公共直流快速充电网络。evGo 的充电站网络为消费者和企业提供电动汽车充电基础设施。

HCW Biologics

HCW Biologics

  • The Trade: HCW Biologics Inc. (NASDAQ:HCWB) CFO Rebecca Byam acquired a total of 58,486 shares at an average price of $1.56. The insider spent around $91.08 thousand to buy those shares.
  • What's Happening: HCW Biologics posted in-line loss for its first quarter.
  • What HCW Biologics Does: HCW Biologics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen the health span by disrupting the link between chronic, low-grade inflammation and age-related diseases.
  • Bioventus

  • The Trade: Bioventus Inc. (NASDAQ:BVS) Interim CEO Anthony Bihl III acquired a total of 125,000 shares at an average price of $2.33. To acquire these shares, it cost around $290.99 thousand.
  • What's Happening: Bioventus posted better-than-expected quarterly sales.
  • What Bioventus Does: Bioventus Inc is a medical technology company. The company is engaged in developing and commercializing clinically differentiated treatments that engage and enhance the body's natural healing process.
  • 这笔交易: HCW Biologics Inc. (纳斯达克股票代码:HCWB)首席财务官丽贝卡·拜亚姆 共收购了58,486股股票 平均价格为1.56美元。内部人士花费了约91.08万美元购买这些股票。
  • 发生了什么:HCW Biologics公布了第一季度的在线亏损。
  • HCW Biologics 是做什么的: HCW Biologics Inc是一家处于临床阶段的生物制药公司,专注于发现和开发新的免疫疗法,通过打破慢性、低度炎症与年龄相关疾病之间的联系来延长健康寿命。
  • 生物文图斯

  • 这笔交易: Bioventus Inc. (纳斯达克股票代码:BVS)临时首席执行官安东尼·比尔三世 共收购了12.5万股股票 平均价格为2.33美元。收购这些股票的成本约为290.99万美元。
  • 发生了什么:Bioventus公布的季度销售额好于预期。
  • Bioventus 在做什么: Bioventus Inc是一家医疗技术公司。该公司正在开发和商业化临床差异化疗法,这些疗法涉及和增强人体的自然愈合过程。

Check This Out: Top 5 Industrials Stocks That May Collapse In May

看看这个: 五月份可能暴跌的五大工业股

Don't forget to check out our premarket coverage here

别忘了在这里查看我们的上市前报道

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发